Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04HBH
|
|||
Former ID |
DIB009542
|
|||
Drug Name |
AM-3701
|
|||
Synonyms |
Cathepsin K inhibitors (oral, osteoporosis/bone metastasis), Amura
Click to Show/Hide
|
|||
Indication | Bone metastases [ICD-11: 2D50; ICD-10: C79.5; ICD-9: 198.5] | Investigative | [1] | |
Company |
Amura Therapeutics Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathepsin K (CTSK) | Target Info | Inhibitor | [1] |
KEGG Pathway | Lysosome | |||
Osteoclast differentiation | ||||
Toll-like receptor signaling pathway | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
RANKL Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
Activation of Matrix Metalloproteinases | ||||
Trafficking and processing of endosomal TLR | ||||
MHC class II antigen presentation | ||||
WikiPathways | RANKL/RANK Signaling Pathway | |||
Osteoclast Signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2350). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.